Elon Musk says Neuralink will test chips in human brains soon

At this point, you know the drill with Elon Musk promises.
 By 
Alex Perry
 on 
Neuralink logo in a human head
This is your brain on Musk. Credit: Jakub Porzycki/NurPhoto via Getty Images

Elon Musk is making promises (he likely can't keep) again.

The billionaire, who claimed Tesla's Cybertruck would begin production this year (spoiler alert: it didn’t) and who also proclaimed he’d make his own smartphone if he had to (spoiler alert: he probably won’t), has now made perhaps his loftiest business claim yet. Neuralink, Musk's biotech company that specializes in making brain chips to restore functionality to disabled bodies, will reportedly begin testing on human subjects soon.

As reported by Bloomberg, Musk made the statement in a nearly three-hour-long Neuralink recruitment event on Wednesday, the entirety of which can be viewed on YouTube. During the event, Musk intimated that human trials could begin in the next six months pending approval from the U.S. Food and Drug Administration for the device, which is roughly the size of a small stack of coins and would be implanted into the brain by a surgery-performing robot. 


You May Also Like

Once implanted, the device would purportedly allow the brain to wirelessly interface with a computer, though Musk said the company is also working on devices to restore vision to the blind and movement to those with paralysis.

Musk even said he’d get one implanted in himself eventually.

There are, of course, major concerns to be had about all of this. The New York Times quoted multiple experts who suggested that claims like restoring full vision to blind people are far-fetched given the current state of technology. One expert also took umbrage with the idea of implanting chips in able-bodied people, as the company's stated goal is to theoretically restore functionality to those who have lost it.

At least one test monkey has died as a result of Neuralink’s research, as well, so the safety of test subjects is another potential issue to worry about. Bloomberg’s report did indicate that Neuralink has since taken steps to increase the comfort and safety of animal test subjects over time.

As with all things Musk, it’s probably best to take a wait-and-see approach with Neuralink’s promises. After all, he still needs FDA approval to move forward. One must simply look at the fact that SpaceX hasn’t sent anyone to Mars yet and how you can’t even pay for Twitter Blue right now to understand that these "Musk-y things" take time. 

That is, if they happen at all.

Topics Elon Musk

journalist alex perry looking at a smartphone
Alex Perry
Tech Reporter

Alex Perry is a tech reporter at Mashable who primarily covers video games and consumer tech. Alex has spent most of the last decade reviewing games, smartphones, headphones, and laptops, and he doesn’t plan on stopping anytime soon. He is also a Pisces, a cat lover, and a Kansas City sports fan. Alex can be found on Bluesky at yelix.bsky.social.

Mashable Potato

Recommended For You
Elon Musk’s SpaceX acquires Elon Musk's xAI, including social media platform X
SpaceX, xAI, and Grok logos

Elon Musk: Tesla FSD will soon become subscription-only
Inside a Tesla, a driver uses Full Self Driving.

AI chatbots like ChatGPT are using info from Elon Musk's Grokipedia, report reveals
Grokipedia logo on mobile device

Takeaways from Elon Musk's xAI all-hands meeting: Ancient aliens, corporate structure, space catapults
Elon Musk and xAI logo

Elon Musk found liable for defrauding Twitter investors
Elon Musk arrives at federal court on March 4, 2026 in San Francisco, California.

Trending on Mashable
NYT Connections hints today: Clues, answers for April 3, 2026
Connections game on a smartphone

Wordle today: Answer, hints for April 3, 2026
Wordle game on a smartphone

What's new to streaming this week? (April 3, 2026)
A composite of images from film and TV streaming this week.

Google launches Gemma 4, a new open-source model: How to try it
Google Gemma

The biggest stories of the day delivered to your inbox.
These newsletters may contain advertising, deals, or affiliate links. By clicking Subscribe, you confirm you are 16+ and agree to our Terms of Use and Privacy Policy.
Thanks for signing up. See you at your inbox!